Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Colombo

Showing results (161-170 of 169) with videos related to

Pageof 17
Sort By:
You have reached the last page of results.This site can display upto 169 results.
Open Forum Infectious Diseases|December 15, 2021
COVID-19 Outcomes Among US Military Health System Beneficiaries Include Complications Across Multiple Organ Systems and Substantial Functional ImpairmentStephanie A Richard, Simon D Pollett, Charlotte A Lanteri, et al.
The Journal of Infectious Diseases|October 21, 2021
Durability of SARS-CoV-2-Specific T-Cell Responses at 12 Months PostinfectionZhongyan Lu, Eric D Laing, Jarina Pena DaMata, et al.
JAMA Network Open|January 18, 2023
Persistent COVID-19 Symptoms at 6 Months After Onset and the Role of Vaccination Before or After SARS-CoV-2 InfectionStephanie A Richard, Simon D Pollett, Anthony C Fries, et al.
Open Forum Infectious Diseases|December 22, 2023
Decreased Self-reported Physical Fitness Following SARS-CoV-2 Infection and the Impact of Vaccine Boosters in a Cohort StudyStephanie A Richard, Ann I Scher, Jennifer Rusiecki, et al.
The Journal of Infectious Diseases|June 25, 2024
Precision symptom phenotyping identifies early clinical and proteomic predictors of distinct COVID-19 sequelaeNusrat J Epsi, Josh G Chenoweth, Paul W Blair, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 24, 2022
Understanding "Hybrid Immunity": Comparison and Predictors of Humoral Immune Responses to Severe Acute Respiratory Syndrome Coronavirus 2 Infection (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) VaccinesNusrat J Epsi, Stephanie A Richard, David A Lindholm, et al.
Cell Host & Microbe|November 10, 2022
Antigenic cartography of well-characterized human sera shows SARS-CoV-2 neutralization differences based on infection and vaccination historyWei Wang, Sabrina Lusvarghi, Rahul Subramanian, et al.
Open Forum Infectious Diseases|June 29, 2023
Evaluating Demographic Representation in Clinical Trials: Use of the Adaptive Coronavirus Disease 2019 Treatment Trial (ACTT) as a Test CaseAna M Ortega-Villa, Noreen A Hynes, Corri B Levine, et al.
Annals of Internal Medicine|November 28, 2022
Temporal Improvements in COVID-19 Outcomes for Hospitalized Adults: A Post Hoc Observational Study of Remdesivir Group Participants in the Adaptive COVID-19 Treatment TrialGail E Potter, Tyler Bonnett, Kevin Rubenstein, et al.
Pageof 17

Showing results (161-170 of 169) with videos related to

Sort By:
Pageof 17
You have reached the last page of results.This site can display upto 169 results.
Open Forum Infectious Diseases|December 15, 2021
COVID-19 Outcomes Among US Military Health System Beneficiaries Include Complications Across Multiple Organ Systems and Substantial Functional ImpairmentStephanie A Richard, Simon D Pollett, Charlotte A Lanteri, et al.
The Journal of Infectious Diseases|October 21, 2021
Durability of SARS-CoV-2-Specific T-Cell Responses at 12 Months PostinfectionZhongyan Lu, Eric D Laing, Jarina Pena DaMata, et al.
JAMA Network Open|January 18, 2023
Persistent COVID-19 Symptoms at 6 Months After Onset and the Role of Vaccination Before or After SARS-CoV-2 InfectionStephanie A Richard, Simon D Pollett, Anthony C Fries, et al.
Open Forum Infectious Diseases|December 22, 2023
Decreased Self-reported Physical Fitness Following SARS-CoV-2 Infection and the Impact of Vaccine Boosters in a Cohort StudyStephanie A Richard, Ann I Scher, Jennifer Rusiecki, et al.
The Journal of Infectious Diseases|June 25, 2024
Precision symptom phenotyping identifies early clinical and proteomic predictors of distinct COVID-19 sequelaeNusrat J Epsi, Josh G Chenoweth, Paul W Blair, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 24, 2022
Understanding "Hybrid Immunity": Comparison and Predictors of Humoral Immune Responses to Severe Acute Respiratory Syndrome Coronavirus 2 Infection (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) VaccinesNusrat J Epsi, Stephanie A Richard, David A Lindholm, et al.
Cell Host & Microbe|November 10, 2022
Antigenic cartography of well-characterized human sera shows SARS-CoV-2 neutralization differences based on infection and vaccination historyWei Wang, Sabrina Lusvarghi, Rahul Subramanian, et al.
Open Forum Infectious Diseases|June 29, 2023
Evaluating Demographic Representation in Clinical Trials: Use of the Adaptive Coronavirus Disease 2019 Treatment Trial (ACTT) as a Test CaseAna M Ortega-Villa, Noreen A Hynes, Corri B Levine, et al.
Annals of Internal Medicine|November 28, 2022
Temporal Improvements in COVID-19 Outcomes for Hospitalized Adults: A Post Hoc Observational Study of Remdesivir Group Participants in the Adaptive COVID-19 Treatment TrialGail E Potter, Tyler Bonnett, Kevin Rubenstein, et al.
Pageof 17